• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伤害感受素拮抗剂Ac-RYYRIK-NH2受体结合的结构要求

Structural requirements of nociceptin antagonist Ac-RYYRIK-NH2 for receptor binding.

作者信息

Kawano Chiaki, Okada Kazushi, Honda Takeshi, Nose Takeru, Sakaguchi Kazuyasu, Costa Tommaso, Shimohigashi Yasuyuki

机构信息

Laboratory of Structure-Function Biochemistry, Faculty and Graduate School of Sciences, Kyushu University, Fukuoka 812-8581, Japan.

出版信息

J Pept Sci. 2002 Oct;8(10):561-9. doi: 10.1002/psc.415.

DOI:10.1002/psc.415
PMID:12450325
Abstract

Ac-RYYRIK-NH2 is a peptide isolated from the peptide library as an antagonist that inhibits the biological activities of nociceptin, a hyperalgesic neuropeptide. In order to clarify the structural requirements of this peptide for binding to the nociceptin receptor ORL1, systematic structure-activity studies were carried out. The result of Ala-scanning indicated that the N-terminal tripeptide RYY(= Arg-Tyr-Tyr) is crucially important for binding to the ORL1 receptor. Residual truncations from the N- or C-terminus revealed the special importance of the N-terminal Arg residue. The removal of protecting groups indicated that the N-terminal acetyl group is essential, but the C-terminal amide group is insignificant. These results indicated the conspicuous importance of acetyl-Arg at position 1 of Ac-RYYRIK-NH2 as a key structure allowing binding to the receptor. To investigate the binding site of this peptide in the ORL1 receptor, we synthesized and assayed a series of analogues of the nociceptin dibasic repeat region, residues 8-13 of RKSARK. None of the derivatives were active. Ac-RYYRIK-NH2 was inactive for the mu opioid receptor to which nociceptin binds with considerable strength. All the results suggested that the mode of binding between Ac-RYYRIK-NH2 and the ORL1 receptor is different to that between the ORL1 receptor and nociceptin, and that it may consist of interaction with the receptor site to which nociceptin(1-7) or -(14-17) binds.

摘要

Ac-RYYRIK-NH2是从肽库中分离出的一种肽,作为拮抗剂可抑制伤害感受素(一种痛觉过敏神经肽)的生物活性。为了阐明该肽与伤害感受素受体ORL1结合的结构要求,开展了系统的构效关系研究。丙氨酸扫描结果表明,N端三肽RYY(=精氨酸-酪氨酸-酪氨酸)对于与ORL1受体结合至关重要。从N端或C端进行的残留截短显示出N端精氨酸残基的特殊重要性。去除保护基团表明N端乙酰基是必需的,但C端酰胺基并不重要。这些结果表明,Ac-RYYRIK-NH2第1位的乙酰化精氨酸作为允许与受体结合的关键结构具有显著重要性。为了研究该肽在ORL1受体中的结合位点,我们合成并检测了一系列伤害感受素双碱性重复区域(RKSARK的8-13位残基)的类似物。这些衍生物均无活性。Ac-RYYRIK-NH2对μ阿片受体无活性,而伤害感受素与该受体有相当强的结合力。所有结果表明,Ac-RYYRIK-NH2与ORL1受体之间的结合模式不同于ORL1受体与伤害感受素之间的结合模式,且可能由与伤害感受素(1-7)或-(14-17)结合的受体位点相互作用组成。

相似文献

1
Structural requirements of nociceptin antagonist Ac-RYYRIK-NH2 for receptor binding.伤害感受素拮抗剂Ac-RYYRIK-NH2受体结合的结构要求
J Pept Sci. 2002 Oct;8(10):561-9. doi: 10.1002/psc.415.
2
Tritium-labelled isovaleryl-RYYRIK-NH2 as potential antagonist probe for ORL1 nociceptin receptor.氚标记的异戊酰基-RYYRIK-NH2作为阿片受体样1孤啡肽受体的潜在拮抗剂探针。
Bioorg Med Chem. 2014 Nov 1;22(21):5902-9. doi: 10.1016/j.bmc.2014.09.018. Epub 2014 Sep 16.
3
N-methylthioacetylation of RYYRIK-NH2 with enhanced specific binding affinity and high antagonist activity for nociceptin ORL1 receptor.RYYRIK-NH2的N-甲硫基乙酰化,对孤啡肽ORL1受体具有增强的特异性结合亲和力和高拮抗剂活性。
Bioorg Med Chem. 2014 Nov 1;22(21):5721-6. doi: 10.1016/j.bmc.2014.09.049.
4
Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist.对孤啡肽受体(ORL1)部分激动剂进行设计修饰,以转化为高效拮抗剂。
Bioorg Med Chem. 2008 Mar 1;16(5):2635-44. doi: 10.1016/j.bmc.2007.11.043. Epub 2007 Nov 21.
5
Synthesis and receptor binding properties of chimeric peptides containing a mu-opioid receptor ligand and nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-amide.含有μ-阿片受体配体和孤啡肽/孤啡肽FQ受体配体Ac-RYYRIK-酰胺的嵌合肽的合成及受体结合特性
Bioorg Med Chem Lett. 2006 Sep 15;16(18):4839-41. doi: 10.1016/j.bmcl.2006.06.060. Epub 2006 Jun 30.
6
Receptor binding properties and antinociceptive effects of chimeric peptides consisting of a micro-opioid receptor agonist and an ORL1 receptor antagonist.由μ-阿片受体激动剂和孤啡肽受体拮抗剂组成的嵌合肽的受体结合特性及镇痛作用
Biol Pharm Bull. 2007 Jul;30(7):1260-4. doi: 10.1248/bpb.30.1260.
7
Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides.新型孤啡肽/孤啡肽原类似物和 N/OFQ-RYYRIK 杂合肽的生化和药理学研究。
Peptides. 2019 Feb;112:106-113. doi: 10.1016/j.peptides.2018.11.010. Epub 2018 Dec 1.
8
Opioid receptor-like 1 (ORL1) receptor binding and the biological properties of Ac-Arg-Tyr-Tyr-Arg-Ile-Arg-NH2 and its analogs.阿片样物质受体样1(ORL1)受体结合以及Ac-Arg-Tyr-Tyr-Arg-Ile-Arg-NH2及其类似物的生物学特性。
J Pept Sci. 2007 Oct;13(10):672-8. doi: 10.1002/psc.900.
9
Capturing of the free cysteine residue in the ligand-binding site by affinity labeling of the ORL1 nociceptin receptor.通过 ORL1 孤啡肽受体的亲和标记捕获配体结合位点中的游离半胱氨酸残基。
Bioorg Med Chem. 2011 Dec 15;19(24):7597-602. doi: 10.1016/j.bmc.2011.10.024. Epub 2011 Oct 17.
10
Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.阿片样物质受体样受体ORL1对天然存在的伤害感受肽孤啡肽化学修饰的敏感性。
J Biol Chem. 1996 Sep 27;271(39):23642-5. doi: 10.1074/jbc.271.39.23642.

引用本文的文献

1
UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.UFP-112 是一种强效且长效的 Nociceptin/孤啡肽受体激动剂。
CNS Neurosci Ther. 2011 Jun;17(3):178-98. doi: 10.1111/j.1755-5949.2009.00107.x. Epub 2010 May 18.